Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Transcutaneous needle-free injection of botulinum toxin: a novel treatment of childhood constipation and anal fissure
Journal of Pediatric Surgery, 09/10/09
Keshtgar AS et al. – Transcutaneous needle–free injection of botulinum toxin into the external anal sphincter is a novel and safe new treatment of chronic idiopathic constipation and anal fissure in children. A second injection may be required in 20% of patients.
Related Articles
Constipation in the elderly: investigation and management
Aging Health, 10/07/09
Relevance Score: 90%
A Randomized Controlled Trial of Enemas in Combination With Oral Laxative Therapy for Children With Chronic Constipation
Clinical Gastroenterology and Hepatology, 10/09/09
Relevance Score: 87%
Phase 2 data from oral NKTR-118 presented at American College of Gastroenterology in San Diego
AstraZeneca, 10/28/09
Relevance Score: 84%
Systematic review of Chinese herbal medicine for functional constipation
World Journal of Gastroenterology, 10/26/09
Relevance Score: 83%
A Feasibility Study of Probiotics Pretreatment as a Bowel Preparation for Colonoscopy in Constipated Patients
Digestive Diseases and Sciences, 10/22/09
Relevance Score: 83%
Today in Peds Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Current issues in the management of paediatric viral hepatitis
Liver International, 12/09/09
Therapeutic intussusception in necrotizing enterocolitis: a novel surgical strategy
Pediatric Surgery International, 12/09/09
No Role for Increased Rectal Compliance in Pediatric Functional Constipation
Gastroenterology, 12/09/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease
Clinical and Experimental Gastroenterology, 12/09/09
Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
Gastroenterology, 12/09/09
Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
Gastroenterology, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


